ROYCE & ASSOCIATES LLC 13D and 13G filings for Meridian Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-31 11:06 am Sale |
2022-12-31 | 13G | Meridian Bioscience, Inc. VIVO |
ROYCE & ASSOCIATES LLC | 169,512 0.390% |
-2,026,122 (-92.28%) |
Filing |
| 2022-01-21 2:15 pm Purchase |
2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO |
ROYCE & ASSOCIATES LLC | 2,195,634 5.050% |
2,195,634 (New Position) |
Filing |